Orthofix Medical (OFIX) Gains from Investment Securities (2018 - 2026)

Orthofix Medical (OFIX) has 9 years of Gains from Investment Securities data on file, last reported at $750000.0 in Q1 2026.

• Quarterly Gains from Investment Securities rose 222.95% year-over-year to $750000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220000.0 (down 95.7% YoY) and the FY2025 annual result came in at -$1.1 million, down 116.52% from the prior year.
• Gains from Investment Securities advanced to $750000.0 in Q1 2026, from $660000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $3.1 million in Q2 2024 to a low of -$10.7 million in Q2 2022.
• A 5-year average of -$892666.7 and a median of -$600000.0 in 2023 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities tumbled 580.25% — and 2024, when it surged 346.25%.
• Tracing OFIX's Gains from Investment Securities over 5 years: stood at -$986000.0 in 2022, then jumped by 39.15% to -$600000.0 in 2023, then soared by 215.0% to $690000.0 in 2024, then fell by 4.35% to $660000.0 in 2025, then advanced by 13.64% to $750000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $750000.0 (Q1 2026), $660000.0 (Q4 2025), and -$427000.0 (Q3 2025), per Business Quant data.